Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

NWBO management is good at shutting down accountability

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
HappyLibrarian Member Profile
 
Followed By 33
Posts 5,334
Boards Moderated 1
Alias Born 03/29/15
160x600 placeholder
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference on July 21 InvestorsHub NewsWire - 7/19/2021 7:00:00 AM
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference Tomorrow.  Register Now InvestorsHub NewsWire - 7/6/2021 7:00:00 AM
Sino United (OTC Pink: SUIC) $200 Million Commitment, Signs with Suntech, the Largest Taiwan O2O Company. InvestorsHub NewsWire - 6/30/2021 7:30:00 AM
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference Tomorrow!  Register Now InvestorsHub NewsWire - 6/22/2021 7:00:00 AM
CEO's Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 6/7/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/24/2021 4:35:22 PM
Northwest Bio gaining attention as investors await phase 3 GBM data Seeking Alpha - 5/24/2021 11:16:44 AM
CEO's Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/24/2021 7:03:10 AM
IQST Signals BUY InvestorsHub NewsWire - 5/20/2021 9:43:19 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 5:17:07 PM
CEO Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/11/2021 7:00:00 AM
Nightfood, Inc. (OTCQB: NGTF) Joins Pepsico (NYSE: PEP), Unilever (NYSE: UL) and Bayer at Event InvestorsHub NewsWire - 5/5/2021 6:28:08 AM
Nightfood, Inc. (OTCQB: NGTF) in Walmart (NYSE: WMT) Coast to Coast over 1,000 Locations InvestorsHub NewsWire - 4/20/2021 7:09:50 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/31/2021 4:56:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/5/2021 8:32:22 AM
Emerging Growth Conference 2 Announced for March 3, 2021 Niche Companies in Technology, AR, eCommerce, Beverage and more .... InvestorsHub NewsWire - 3/1/2021 6:28:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/26/2021 4:55:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/19/2021 4:07:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/15/2021 7:21:09 AM
The FDA Calendar Review Dates Can Play a Big Role in Timing Your Trades, But Not the Way You May Think InvestorsHub NewsWire - 1/7/2021 8:00:00 AM
Biotech Companies; Recent Milestones and Potential Upside InvestorsHub NewsWire - 12/22/2020 8:05:00 AM
TNS is on the Hunt for the Next OTC Home Run Stock, Feature Report InvestorsHub NewsWire - 11/30/2020 8:20:00 AM
Immune Therapeutics, Inc. Spinoff Cytocom, Inc. Appoints BioPharm Industry Veteran as New Chief Operating Officer InvestorsHub NewsWire - 11/11/2020 9:11:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/10/2020 4:58:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2020 2:16:52 PM
HappyLibrarian   Wednesday, 06/16/21 05:58:13 PM
Re: biosectinvestor post# 384863
Post # of 391709 
NWBO management is good at shutting down accountability by starving shareholders of information just like a fire is starved of oxygen.

Almost any criticism can be rebutted by "We don't know what they know" and I believe this rebuttal is invalid because it is generally NWBO that prevents us from knowing more than a small fraction of what they know.

It is almost like Enron where people including seasoned analysts had to take on faith that nothing illegal was going on despite the profit increases year over year being suspicious because after all, how could such a big company with so many respected people involved be a scam? Don't they know they would face serious charges and are going to get caught? That must mean everything is being done legally and the lack of transparency is required to protect their competitive advantage. Naturally the few analysts who initially had issues were attacked and sidelined.

We should not have to wait to find out when TLD is released, especially since management gets to control the timetable for TLD (they tacked on the article not the FDA for example).

Now maybe side from a blip on the management's team's resume the parallels are irrelevant. They probably are since NWBO is not pretending to make profits as Enron pretended (we were just discussing NWBO's telling us they will not make money in the near future from sales of products after all).

But I do not believe that management can create an information blackout and then get to use it or for anyone else to get to use as the answer to any concerns.




Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences